REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Onkopatologiai Diagnosztikai Kft. (Hungary)

Main Activities: General Medical and Surgical Hospitals
Full name: Onkopatologiai Diagnosztikai Kft. Profile Updated: August 16, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Hungarian Download a sample report

Onkopatologiai Diagnosztikai Kft. is an enterprise in Hungary, with the main office in Budapest. The company operates in the General Medical and Surgical Hospitals industry. It was first established on October 14, 2011. It currently has a total number of 18 (2023) employees. The company’s latest financial report indicates a net sales revenue increase of 32.06% in 2022. There was a total negative growth of 0.16% in Onkopatologiai Diagnosztikai Kft.’s total assets over the same period. In 2022, Onkopatologiai Diagnosztikai Kft.’s net profit margin increased by 5.01%.

Headquarters
Sorgyar utca 63.
Budapest; Budapest; Postal Code: 1104

Contact Details: Purchase the Onkopatologiai Diagnosztikai Kft. report to view the information.

Basic Information
Total Employees:
Purchase the Onkopatologiai Diagnosztikai Kft. report to view the information.
Outstanding Shares:
Purchase the Onkopatologiai Diagnosztikai Kft. report to view the information.
Registered Capital:
Purchase the Onkopatologiai Diagnosztikai Kft. report to view the information.
Incorporation Date:
October 14, 2011
Key Executives
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Onkopatologiai Diagnosztikai Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
32.06%▲
Total operating revenue
33.84%▲
Operating profit (EBIT)
98.92%▲
EBITDA
55.89%▲
Net Profit (Loss) for the Period
299.89%▲
Total assets
-0.16%▼
Total equity
-1.68%▼
Operating Profit Margin (ROS)
3.86%▲
Net Profit Margin
5.01%▲
Return on Equity (ROE)
10.79%▲
Quick Ratio
-1.77%▼
Cash Ratio
-1.58%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo